Which Treatment for Which Patient: Rectal Cancer Management After PROSPECT Trial

Oncology (Williston Park). 2024 May 13;38(5):187-190. doi: 10.46883/2024.25921019.

Abstract

Determining treatment options for patients with locally advanced rectal cancer after the PROSPECT trial data readout adds an important level to the decision-making process.

Trial registration: ClinicalTrials.gov NCT01515787.

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Fluorouracil / administration & dosage
  • Fluorouracil / therapeutic use
  • Humans
  • Leucovorin / administration & dosage
  • Leucovorin / therapeutic use
  • Randomized Controlled Trials as Topic
  • Rectal Neoplasms* / pathology
  • Rectal Neoplasms* / therapy

Substances

  • Fluorouracil
  • Leucovorin

Associated data

  • ClinicalTrials.gov/NCT01515787